Fewer New Tiotropium/Olodaterol Users Escalate to Triple Therapy vs New Tiotropium Monotherapy Users
The researchers’ main goal was to compare real-world time-to-escalation to triple therapy for COPD without asthma among new users of tiotropium/olodaterol vs users of tiotropium monotherapy.